113 related articles for article (PubMed ID: 6129680)
1. Evidence that endogenous thyrotropin-releasing hormone (TRH) may control vagal efferents to thyroid gland: neural inhibition by central administration of TRH antiserum.
Tonoue T; Somiya H; Matsumoto H; Ogawa N; Leppäluoto J
Regul Pept; 1982 Oct; 4(5):293-8. PubMed ID: 6129680
[TBL] [Abstract][Full Text] [Related]
2. Stimulation by thyrotropin-releasing hormone of vagal outflow to the thyroid gland.
Tonoue T
Regul Pept; 1982 Jan; 3(1):29-39. PubMed ID: 6119741
[TBL] [Abstract][Full Text] [Related]
3. Central somatostatin prevents vagal efferent nerve excitation produced by TRH but not by 2-deoxy-D-glucose.
Masuda M; Kanai S; Miyasaka K
Am J Physiol; 1997 Feb; 272(2 Pt 1):G351-6. PubMed ID: 9124360
[TBL] [Abstract][Full Text] [Related]
4. Intracisternal TRH and RX 77368 potently activate gastric vagal efferent discharge in rats.
O-Lee TJ; Wei JY; Taché Y
Peptides; 1997; 18(2):213-9. PubMed ID: 9149293
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanism of growth hormone and thyrotropin responses to somatostatin antiserum in anesthetized rats.
Chihara K; Arimura A; Chihara M; Schally AV
Endocrinology; 1978 Nov; 103(5):1916-23. PubMed ID: 107024
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
Michalkiewicz M; Suzuki M; Kato M
Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptides as central integrators of autonomic nerve activity: effects of TRH, SRIF, VIP and bombesin on gastric and adrenal nerves.
Somiya H; Tonoue T
Regul Pept; 1984 Sep; 9(1-2):47-52. PubMed ID: 6150518
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system action of thyrotropin-releasing hormone to increase gastric mucosal blood flow in the rat.
Thiefin G; Taché Y; Leung FW; Guth PH
Gastroenterology; 1989 Aug; 97(2):405-11. PubMed ID: 2501141
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of gastric acid output and mucosal blood flow by tripeptide thyrotropin releasing hormone microinjected into the dorsal motor nucleus of the vagus in rats.
Okuma Y; Osumi Y; Ishikawa T; Mitsuma T
Jpn J Pharmacol; 1987 Feb; 43(2):173-8. PubMed ID: 3106685
[TBL] [Abstract][Full Text] [Related]
10. Influence of endogenous somatostatin on growth hormone and thyrotropin secretion in neonatal rats.
Oliver C; Giraud P; Lissitzky JC; Cote J; Boudouresque F; Gillioz P; Conte-Devolx B
Endocrinology; 1982 Mar; 110(3):1018-22. PubMed ID: 6120074
[TBL] [Abstract][Full Text] [Related]
11. Selective autonomic nervous control of thyroid hormone and calcitonin secretion during metabolic and cardiorespiratory activation by intracisternal thyrotropin-releasing hormone (TRH).
Riedel W; Burke SL
J Auton Nerv Syst; 1988 Sep; 24(1-2):157-73. PubMed ID: 3145296
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin-releasing hormone: effects on identified neurons of the dorsal vagal complex.
McCann MJ; Hermann GE; Rogers RC
J Auton Nerv Syst; 1989 Mar; 26(2):107-12. PubMed ID: 2498419
[TBL] [Abstract][Full Text] [Related]
13. Antiserum to rat growth hormone (GH)-releasing factor suppresses but does not abolish antisomatostatin-induced GH release in the rat.
Thomas CR; Groot K; Arimura A
Endocrinology; 1985 Jun; 116(6):2174-8. PubMed ID: 2859982
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of gastric acid secretion by immunoneutralization of endogenous brain thyrotropin-releasing hormone.
Hernandez DE; Jennes L; Emerick SG
Brain Res; 1987 Jan; 401(2):381-4. PubMed ID: 2880645
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin-releasing hormone-induced changes in electroencephalographic and vagal activity in the cross-circulated brain of the rat.
Tonoue T; Nishimura H; Tokushige K; Seino K
Brain Res; 1986 Jul; 378(2):394-7. PubMed ID: 3089542
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying intracisternal TRH-induced stimulation of gastric acid secretion in rats.
Taché Y; Goto Y; Hamel D; Pekary A; Novin D
Regul Pept; 1985 Dec; 13(1):21-30. PubMed ID: 3937184
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic somatostatin mediates the suppression of growth hormone secretion by centrally administered thyrotropin-releasing hormone in conscious rats.
Katakami H; Arimura A; Frohman LA
Endocrinology; 1985 Sep; 117(3):1139-44. PubMed ID: 2862016
[TBL] [Abstract][Full Text] [Related]
18. Thyrotropin-releasing hormone and somatostatin inhibit each others release in vitro in the rat retina.
Mitsuma T; Hirooka Y; Kayama M; Mori Y; Adacht K; Takagi J; Wago T; Ping J; Nogimori T
Exp Clin Endocrinol Diabetes; 1998; 106(2):140-2. PubMed ID: 9628246
[TBL] [Abstract][Full Text] [Related]
19. The effect of intracisternal injection of thyrotropin-releasing hormone on gastric and duodenal motility in the urethane-anaesthetized rat.
Davison JS; Wootton P
Exp Physiol; 1991 Nov; 76(6):983-6. PubMed ID: 1768421
[TBL] [Abstract][Full Text] [Related]
20. Effects of anti-thyrotropin-releasing hormone anti-serum treatment during the neonatal period on the development of rat thyroid function.
Mitsuma T; Nogimori T
Horm Metab Res; 1984 Aug; 16(8):428-30. PubMed ID: 6432670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
